Equine melanocytic neoplasm (EMN) is a skin tumor affecting grey horses over 15 years of age, with limitations to current therapeutic and preventative strategies. This study aims to identify potential protein expressions and biomarkers for EMN through proteomic and immunohistochemical analysis of tissue biopsy samples from normal grey horses and those at early and severe stages of EMN.